Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: external quality assessment

Abstract

This external quality assessment study showed that manufacturers of blood products have reached a high level of proficiency that fully complies with the European Pharmacopoeia requirements. This finding is reassuring in the context of the safety of blood products.